• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2):综述。

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review.

机构信息

Department of Laboratory Medicine, Affiliated Hospital of Nantong University, No 20, Xisi Road, Nantong, 226001, China.

出版信息

Mol Cancer. 2020 Jun 2;19(1):100. doi: 10.1186/s12943-020-01218-1.

DOI:10.1186/s12943-020-01218-1
PMID:32487159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7264920/
Abstract

In recent years, the prevalence and spread of coronavirus has had a huge impact on global public health. Due to the incomplete understanding of the pathogenic mechanism of the virus, it is difficult for humans to fight against the virus quickly and effectively once the outbreak occurs. In early 2020, a novel coronavirus was discovered in Wuhan, China. Soon after, similar cases were found in other countries around the world, and the number of infected people increased rapidly. So far, the global cumulative number of infected people has exceeded 3 million, and more than 200,000 people have died, which has had a huge impact on global human health and economic development. Every outbreak of disease makes a deep impression on mankind. Herein, we summarize the virology, epidemiology, clinical manifestations, diagnosis, treatment and prevention of SARS-CoV-2, and hope that countries can control the outbreak as soon as possible to minimize the loss.

摘要

近年来,冠状病毒的流行和传播对全球公共卫生造成了巨大影响。由于对病毒的致病机制了解不完整,一旦爆发,人类很难快速有效地对抗病毒。2020 年初,在中国武汉发现了一种新型冠状病毒。此后不久,世界其他国家也发现了类似的病例,感染人数迅速增加。到目前为止,全球累计感染人数已超过 300 万,超过 20 万人死亡,这对全球人类健康和经济发展产生了巨大影响。每次疾病爆发都给人类留下了深刻的印象。在此,我们总结了 SARS-CoV-2 的病毒学、流行病学、临床表现、诊断、治疗和预防,希望各国能够尽快控制疫情,将损失降到最低。

相似文献

1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2):综述。
Mol Cancer. 2020 Jun 2;19(1):100. doi: 10.1186/s12943-020-01218-1.
2
COVID-19: what has been learned and to be learned about the novel coronavirus disease.新型冠状病毒病(COVID-19):对新型冠状病毒疾病的认识与探索。
Int J Biol Sci. 2020 Mar 15;16(10):1753-1766. doi: 10.7150/ijbs.45134. eCollection 2020.
3
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.新型严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)的爆发:当前全球状况综述。
J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4.
4
The Novel Coronavirus: A Bird's Eye View.新型冠状病毒:概览
Int J Occup Environ Med. 2020 Apr;11(2):65-71. doi: 10.15171/ijoem.2020.1921. Epub 2020 Feb 5.
5
The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.新型冠状病毒(SARS-CoV-2)爆发的前 75 天:最新进展、预防和治疗。
Int J Environ Res Public Health. 2020 Mar 30;17(7):2323. doi: 10.3390/ijerph17072323.
6
Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China.中国武汉医护人员家庭接触者中的无症状 SARS-CoV-2 感染。
Emerg Infect Dis. 2020 Aug;26(8):1930-1933. doi: 10.3201/eid2608.201016. Epub 2020 Apr 24.
7
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.
8
The Wuhan SARS-CoV-2-What's next for China.武汉的新冠病毒——中国的下一步是什么。
J Med Virol. 2020 Jun;92(6):546-547. doi: 10.1002/jmv.25738. Epub 2020 Mar 18.
9
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情:一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
10
The COVID-19 pandemic.新型冠状病毒肺炎(COVID-19)疫情。
Crit Rev Clin Lab Sci. 2020 Sep;57(6):365-388. doi: 10.1080/10408363.2020.1783198. Epub 2020 Jul 9.

引用本文的文献

1
Potential blocker of SARS-CoV entry and a narrow functionality of its spike protein motifs on Qubevirus platform.严重急性呼吸综合征冠状病毒(SARS-CoV)进入的潜在阻断剂及其刺突蛋白基序在库贝病毒平台上的狭窄功能。
J Biol Chem. 2025 Jun 12;301(7):110371. doi: 10.1016/j.jbc.2025.110371.
2
Manual therapists in Sweden during the COVID-19 pandemic -they remained in business, but how was their work environment and practice impacted?瑞典新冠疫情期间的手法治疗师——他们仍在营业,但他们的工作环境和业务受到了怎样的影响?
PLoS One. 2025 May 27;20(5):e0324245. doi: 10.1371/journal.pone.0324245. eCollection 2025.
3
Impact of COVID-19 on healthcare programs in Zimbabwe: a mixed methods study.

本文引用的文献

1
[Management of COVID-19: the Zhejiang experience].[新型冠状病毒肺炎的管理:浙江经验]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(2):147-157. doi: 10.3785/j.issn.1008-9292.2020.02.02.
2
The importance of naturally attenuated SARS-CoV-2in the fight against COVID-19.自然减毒的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在抗击2019冠状病毒病(COVID-19)中的重要性。
Environ Microbiol. 2020 Jun;22(6):1997-2000. doi: 10.1111/1462-2920.15039.
3
Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals.SARS-CoV-2 的空气动力学分析在两家武汉医院进行。
新冠疫情对津巴布韦医疗保健项目的影响:一项混合方法研究。
BMC Public Health. 2025 May 13;25(1):1749. doi: 10.1186/s12889-025-22791-4.
4
Xuanfei Baidu Decoction Alleviated Sepsis-Induced ALI by Modulating Gut Microbial Homeostasis and Promoting Inflammation Resolution: Bioinformatics and Experimental Study.宣肺败毒方通过调节肠道微生物稳态和促进炎症消退减轻脓毒症诱导的急性肺损伤:生物信息学与实验研究
ACS Omega. 2025 Mar 26;10(13):13105-13121. doi: 10.1021/acsomega.4c10575. eCollection 2025 Apr 8.
5
Atmospheric pressure plasma jet for respiratory face masks decontamination and re-use: Considerations on microbiological efficacy, material impact and product lifecycle.用于呼吸面罩消毒和再利用的大气压等离子体射流:关于微生物功效、材料影响和产品生命周期的考量
PLoS One. 2025 Jan 23;20(1):e0313041. doi: 10.1371/journal.pone.0313041. eCollection 2025.
6
Hospital-based cross-sectional study on the clinical characteristics of children with severe acute respiratory infections in Hungary.匈牙利基于医院的严重急性呼吸道感染患儿临床特征的横断面研究。
BMC Infect Dis. 2024 Nov 9;24(1):1268. doi: 10.1186/s12879-024-10186-6.
7
Neopterin production in relation to COVID-19 in the Haut-Ogooué Province, Gabon.新蝶呤生成与加蓬上奥果韦省 COVID-19 之间的关系。
BMC Infect Dis. 2024 Aug 28;24(1):872. doi: 10.1186/s12879-024-09766-3.
8
Acute Respiratory Tract Infections in Pediatric Populations of Slum Areas: Navigating Challenges and Dynamics of Immune Responses.贫民窟地区儿童群体中的急性呼吸道感染:应对免疫反应的挑战与动态变化
Curr Pediatr Rev. 2025;21(3):245-267. doi: 10.2174/0115733963309043240703115735.
9
COVID-19 Vaccine-Related Movement Disorders: A Systematic Review.新型冠状病毒肺炎疫苗相关运动障碍:一项系统综述
J Mov Disord. 2024 Jul;17(3):322-327. doi: 10.14802/jmd.24001. Epub 2024 Mar 19.
10
Dose Intervals and Time since Final Dose on Changes in Metabolic Indices after COVID-19 Vaccination.新冠疫苗接种后剂量间隔及末次剂量后的时间对代谢指标变化的影响
Vaccines (Basel). 2023 Nov 23;11(12):1746. doi: 10.3390/vaccines11121746.
Nature. 2020 Jun;582(7813):557-560. doi: 10.1038/s41586-020-2271-3. Epub 2020 Apr 27.
4
Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis.意大利北部感染 SARS-CoV-2 的孕妇的阴道分娩:一项回顾性分析。
BJOG. 2020 Aug;127(9):1116-1121. doi: 10.1111/1471-0528.16278. Epub 2020 May 28.
5
Epidemiological Characteristics and Incubation Period of 7015 Confirmed Cases With Coronavirus Disease 2019 Outside Hubei Province in China.中国湖北省外 7015 例新型冠状病毒病确诊病例的流行病学特征和潜伏期。
J Infect Dis. 2020 Jun 16;222(1):26-33. doi: 10.1093/infdis/jiaa211.
6
Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的免疫球蛋白G和IgM抗体概况
Clin Infect Dis. 2020 Nov 19;71(16):2255-2258. doi: 10.1093/cid/ciaa489.
7
COVID-19 outbreak: Migration, effects on society, global environment and prevention.新冠疫情爆发:移民、对社会的影响、全球环境和预防。
Sci Total Environ. 2020 Aug 1;728:138882. doi: 10.1016/j.scitotenv.2020.138882. Epub 2020 Apr 22.
8
Potential fecal transmission of SARS-CoV-2: Current evidence and implications for public health.新冠病毒粪口传播的潜在风险:现有证据及其对公共卫生的影响。
Int J Infect Dis. 2020 Jun;95:363-370. doi: 10.1016/j.ijid.2020.04.057. Epub 2020 Apr 23.
9
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.使用临床级别的可溶性人血管紧张素转化酶 2 抑制工程化人类组织中的 SARS-CoV-2 感染。
Cell. 2020 May 14;181(4):905-913.e7. doi: 10.1016/j.cell.2020.04.004. Epub 2020 Apr 24.
10
Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome.新型冠状病毒肺炎的皮肤表现:巴塞罗那和罗马的经验
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e306-e307. doi: 10.1111/jdv.16530.